Reference record
Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study
NCT05392088
First Published (first received 2022 May 26)https://clinicaltrials.gov/show/NCT05392088 (https://clinicaltrials.gov/show/NCT05392088)
Trial registry recordNo Results
The present retrospective and prospective observational study aims at evaluate the clinical
predictors of myocardial injury in patients hospitalized for COVID-19 infection since the
introduction of vaccines that could allow the development of predictive models as well as
help clinicians in the early assessment of the risk of myocardial injury and the prevention
of the associated unfavourable outcomes.
Furthermore, this study will characterize the cardiovascular outcomes in the post-acute
COVID-19 phase, and it will evaluate for the first time the long-term clinical outcomes of
patients who experienced myocardial injury, possibly paving the way for the implementation of
specific therapies aiming to reduce the cardiovascular risk and the long- term sequelae of
COVID-19